OBJECTIVES: Smoking is a known risk factor for developing chronic pancreatitis and accelerates disease progression. Smoking cessation remains an important treatment recommendation, but little is known about its effects. This study evaluated smoking cessation in this population and its impact on quality of life. METHODS: Twenty-seven smokers with chronic pancreatitis participated in a smoking cessation program incorporating the QuitWorks program and individual counseling. Their smoking cessation rates were compared with a control population (n = 200) consisting of inpatients without chronic pancreatitis who smoked. Smokers were also compared with nonsmokers (n = 25) with chronic pancreatitis in terms of quality-of-life indicators. RESULTS: In 27 patients, 0 had quit smoking at 6 months, 1 at 12 months, and 0 patients at 18 months. There was a 19% quit rate in the control population at the 6-month period. Smokers had a worse quality of life, higher rates of depression and anxiety, and worse coping skills than nonsmokers. CONCLUSIONS: Smoking cessation in the chronic pancreatitis population is extremely challenging, as shown by our 0% quit rate after 18 months. Given that smokers with chronic pancreatitis also experience a worse quality of life, it becomes even more important to stress the importance of smoking cessation in these patients.
OBJECTIVES: Smoking is a known risk factor for developing chronic pancreatitis and accelerates disease progression. Smoking cessation remains an important treatment recommendation, but little is known about its effects. This study evaluated smoking cessation in this population and its impact on quality of life. METHODS: Twenty-seven smokers with chronic pancreatitis participated in a smoking cessation program incorporating the QuitWorks program and individual counseling. Their smoking cessation rates were compared with a control population (n = 200) consisting of inpatients without chronic pancreatitis who smoked. Smokers were also compared with nonsmokers (n = 25) with chronic pancreatitis in terms of quality-of-life indicators. RESULTS: In 27 patients, 0 had quit smoking at 6 months, 1 at 12 months, and 0 patients at 18 months. There was a 19% quit rate in the control population at the 6-month period. Smokers had a worse quality of life, higher rates of depression and anxiety, and worse coping skills than nonsmokers. CONCLUSIONS: Smoking cessation in the chronic pancreatitis population is extremely challenging, as shown by our 0% quit rate after 18 months. Given that smokers with chronic pancreatitis also experience a worse quality of life, it becomes even more important to stress the importance of smoking cessation in these patients.
Authors: Judson A Brewer; Sarah Mallik; Theresa A Babuscio; Charla Nich; Hayley E Johnson; Cameron M Deleone; Candace A Minnix-Cotton; Shannon A Byrne; Hedy Kober; Andrea J Weinstein; Kathleen M Carroll; Bruce J Rounsaville Journal: Drug Alcohol Depend Date: 2011-07-01 Impact factor: 4.492
Authors: Markus Wehler; Ralf Nichterlein; Bernhard Fischer; Michael Farnbacher; Udo Reulbach; Eckhart Georg Hahn; Thomas Schneider Journal: Am J Gastroenterol Date: 2004-01 Impact factor: 10.864
Authors: Stephen F Butler; Kathrine Fernandez; Christine Benoit; Simon H Budman; Robert N Jamison Journal: J Pain Date: 2008-01-22 Impact factor: 5.820
Authors: Thomas C Hall; Giuseppe Garcea; M'Balu A Webb; Dhya Al-Leswas; Matthew S Metcalfe; Ashley R Dennison Journal: J Eval Clin Pract Date: 2014-03-24 Impact factor: 2.431
Authors: Jorge D Machicado; Stephen T Amann; Michelle A Anderson; Judah Abberbock; Stuart Sherman; Darwin L Conwell; Gregory A Cote; Vikesh K Singh; Michele D Lewis; Samer Alkaade; Bimaljit S Sandhu; Nalini M Guda; Thiruvengadam Muniraj; Gong Tang; John Baillie; Randall E Brand; Timothy B Gardner; Andres Gelrud; Christopher E Forsmark; Peter A Banks; Adam Slivka; C Mel Wilcox; David C Whitcomb; Dhiraj Yadav Journal: Am J Gastroenterol Date: 2017-02-28 Impact factor: 10.864
Authors: Thiruvengadam Muniraj; Dhiraj Yadav; Judah N Abberbock; Samer Alkaade; Stephen T Amann; Michelle A Anderson; Peter A Banks; Randall E Brand; Darwin Conwell; Gregory A Cote; Christopher E Forsmark; Timothy B Gardner; Andres Gelrud; Nalini Guda; Michele D Lewis; Joseph Romagnuolo; Bimaljit S Sandhu; Stuart Sherman; Vikesh K Singh; Adam Slivka; Gong Tang; David C Whitcomb; C Mel Wilcox Journal: Pancreatology Date: 2019-02-26 Impact factor: 3.996
Authors: Samuel Y Han; Darwin L Conwell; Philip T Diaz; Amy Ferketich; Christie Y Jeon; Dhiraj Yadav; Phil A Hart Journal: Pancreatology Date: 2022-08-11 Impact factor: 3.977
Authors: Merve Gurakar; Niloofar Y Jalaly; Mahya Faghih; Tina Boortalary; Javad R Azadi; Mouen A Khashab; Christopher Fan; Anthony N Kalloo; Atif Zaheer; Vikesh K Singh; Elham Afghani Journal: Scand J Gastroenterol Date: 2021-10-18 Impact factor: 3.027
Authors: Luis F Lara; Solvejg Wastvedt; James S Hodges; Piotr Witkowski; Martin Wijkstrom; R Matthew Walsh; Vikesh K Singh; Sarah J Schwarzenberg; Timothy L Pruett; Andrew Posselt; Bashoo Naziruddin; Jaimie D Nathan; Katherine A Morgan; Rebecca Mitchell; Varvara A Kirchner; SriPrakash L Mokshagundam; Betul Hatipoglu; Timothy B Gardner; Martin L Freeman; Srinath Chinnakotla; Gregory J Beilman; Maisam Abu-El-Haija; Darwin L Conwell; Melena D Bellin Journal: Pancreas Date: 2021-07-01 Impact factor: 3.243